BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/3/2024 8:49:13 AM | Browse: 107 | Download: 573
 |
Received |
|
2024-03-05 02:54 |
|
Peer-Review Started |
|
2024-03-05 02:54 |
|
First Decision by Editorial Office Director |
|
2024-04-25 07:54 |
|
Return for Revision |
|
2024-04-25 07:54 |
|
Revised |
|
2024-04-26 00:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-05-11 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-05-11 06:30 |
|
Articles in Press |
|
2024-05-11 06:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-23 02:23 |
|
Publish the Manuscript Online |
|
2024-06-03 08:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wei-Nung Liu, Ming-Shen Dai, Felicia Lin and Gen-Min Lin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gen-Min Lin, FACC, FAHA, FESC, MD, PhD, Academic Editor, Academic Fellow, Chief Physician, Department of Medicine, Hualien Armed Forces General Hospital, No. 100 Jinfeng Street, Hualien City 970, Taiwan. farmer507@yahoo.com.tw |
| Key Words |
Hepatitis B virus reactivation; Bruton tyrosine kinase inhibitors; Hematologic malignancies; Solid tumors; Prophylaxis guidelines |
| Core Tip |
This is an invited editorial for the coming paper “Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis”. |
| Publish Date |
2024-06-03 08:49 |
| Citation |
Liu WN, Dai MS, Lin F, Lin GM. Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. World J Gastroenterol 2024; 30(21): 2748-2750 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i21/2748.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i21.2748 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
